Publications

Antiangiogenic tyrosine kinase inhibitors have differential efficacy in clear cell renal cell carcinoma in bone

Download PDF
Resource: Antiangiogenic tyrosine kinase inhibitors have differential efficacy in clear cell renal cell carcinoma in bone

.

Related Articles

Pilot clinical trial of neoadjuvant toll-like receptor 7 agonist (Imiquimod) immunotherapy in early-stage oral squamous cell carcinoma

Link
The association between the tumor immune microenvironments and clinical outcome in low-grade, early-stage endometrial cancer patients

Link